Literature DB >> 28684274

Construction of high level prokaryotic expression and purification system of PD-L1 extracellular domain by using Escherichia coli host cell machinery.

Muhammad Kalim1, Jie Chen1, Shenghao Wang1, Caiyao Lin1, Saif Ullah1, Keying Liang1, Qian Ding1, Shuqing Chen2, Jinbiao Zhan3.   

Abstract

Programmed cell death 1 ligand 1 (PD-L1) is a trans-membrane protein highly expressed on the membrane of cancer cell, which binds inhibitory receptor of PD-1 on the T cells and attenuates anti-tumor immune response.The strategy of blocking PD1 and PD-L1 interaction has been widely used for anti-cancer drug development. The DNA encoding extracellular domain of PD-L1 was cloned and expressed with the pET30(+) and Escherichia coli BL21(DE3) system. Cloning of PD-L1 extracellular domain was confirmed by PCR and enzymatic digestion. Sequence analysis of cloned targeted genes showed 100% homology of original sequence. The recombinant protein was expressed using 1mM/mL IPTG and purified by affinity chromatography on a column of Ni-NTA and confirmed by SDS-PAGE and western blot analysis. Results showed that our constructed pET30(+)/PDL1-ECD system efficiently produces desired recombinant protein with molecular weight of 38.1kDa. The prokaryotic expression system provides an easy method to express PD-L1 extracellular domain that further facilitate the role of PD-1/PD-L1 binding inhibition and helps in valuable drug and antibodies production.
Copyright © 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; CD274; Expression; Immunotherapy; PD-1; PD-L1

Mesh:

Substances:

Year:  2017        PMID: 28684274     DOI: 10.1016/j.imlet.2017.06.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  2 in total

1.  Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapy.

Authors:  Muhammad Kalim; Keying Liang; Muhammad Saleem Iqbal Khan; Jinbiao Zhan
Journal:  Cytotechnology       Date:  2019-05-16       Impact factor: 2.058

2.  Expression of Recombinant CTLA-4 and PD-L1 Proteins Fused with Thioredoxin, and Determination of Their Ligand-Binding Activities.

Authors:  Adish Zhansaya; Nurtleu Malika; Dzantiev Boris; Tursunov Kanat; Mukantayev Kanatbek; Ramankulov Yerlan; Mukanov Kasym
Journal:  Rep Biochem Mol Biol       Date:  2022-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.